A Randomized Phase II Trial of Pre-Operative Chemoradiotherapy With or Without Cetuximab (ERBITUX) in Locally-Advanced Adenocarcinoma of the Rectum.

Trial Profile

A Randomized Phase II Trial of Pre-Operative Chemoradiotherapy With or Without Cetuximab (ERBITUX) in Locally-Advanced Adenocarcinoma of the Rectum.

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Nov 2016

At a glance

  • Drugs Cetuximab (Primary) ; Fluorouracil
  • Indications Rectal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Nov 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 18 Jan 2014 Primary endpoint 'Pathological-response-rate' has not been met.
    • 18 Jan 2014 Results presented at the 2014 Gastrointestinal Cancers Symposium.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top